Close Menu

NEW YORK – Illumina and metagenomics technology firm IDbyDNA announced a strategic partnership and comarketing agreement on Tuesday.

The firms said in a statement that they aim to provide "a complete, streamlined workflow solution for infectious disease applications" of next-generation sequencing, providing pathogen identification as well as information on antimicrobial resistance markers.

Under the terms of the agreement, the partners will comarket IDbyDNA's Explify platform for use with Illumina's NGS instruments and library preparation kits.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.

Nov
10
Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.